News

Published on 18 May 2023 on Benzinga via Yahoo Finance

Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To...

Article preview image

Avrobio Inc (NASDAQ: AVRO) announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of an investigational gene therapy for cystinosis, dubbed AVR-RD-04.

Read the rest of the article
NASDAQ.AVRO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 8 Nov 2023
Is AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 23 Oct 2023
Has AVROBIO (AVRO) Outpaced Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 6 Oct 2023
AVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46%

AVROBIO AVRO announced completing a review of its business encompassing the status of its program...

Zacks via Yahoo Finance 13 Jul 2023
The Petri Dish: FDA delays Sarepta decision; Novartis buys Avrobio drug - Boston Business Journal

Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care...

The Business Journals 25 May 2023
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.42% By Investing.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.42%

Investing.com 22 May 2023
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving...

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Movin...

Investing.com 22 May 2023
Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To...

Avrobio Inc (NASDAQ: AVRO) announced follow-up data demonstrating a durable treatment effect acro...

Benzinga via Yahoo Finance 18 May 2023
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34%

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34%

Investing.com 17 May 2023
8 Best Penny Stocks To Buy Under $1.00

Penny stocks are often found in emerging industries or in industries that require a long period o...

GoBankingRates via AOL 18 Jan 2023

Copyright Statfolio @ 2024

Social Accounts